Health Canada Bans Avastin For Breast Cancer Treatment
Health Canada on Monday suspended its authorization of blockbuster Genentech Inc. drug Avastin for treating breast cancer, citing concerns over its effectiveness and life-threatening risks such as heart attacks....To view the full article, register now.
Already a subscriber? Click here to view full article